Le Lézard
Classified in: Health, Science and technology
Subjects: Event, Advisory

Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar


Quantum-Si Incorporated (NASDAQ: QSI):

WHAT: Esteemed scientist Christopher Mason, Ph.D., of Weill Cornell Medicine, is set to discuss his Two Frontiers Project during an exclusive webinar hosted by GenomeWeb. Dr. Mason will also reveal his plans for using Quantum-Si's benchtop protein sequencer, Platinum® to expand his multiomic research on extremophiles and what is needed for human survival in extreme environments.

WHY: Dr. Mason recently remarked, "To better understand disease and health, we must not only look at nucleic acids, but also other molecules and pivotal proteins. In recent years, the field of proteomics has surged forward. We are now experiencing a remarkable acceleration with advancements in protein sequencing, revealing new biology and post-translational modifications."

WHO: The webinar will feature:

WHEN: The webinar, titled "Characterizing Far-Flung Extremophiles with Next-Generation Protein Sequencingtm," will take place on Wednesday, February 28, at 11:00 a.m. ET.

WHERE: Hosted online by GenomeWeb. Reserve your spot today: https://event.on24.com/wcc/r/4461798/062AF09F1284EB44601D82D2A32B9869?partnerref=QSI

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Companytm, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

About Christopher Mason, Ph.D.

Christopher Mason, Ph.D., is a Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the director of the WorldQuant Initiative for Quantitative Prediction. With over 300 peer-reviewed papers, five patents, and the foundation of numerous biotechnology companies and non-profits, Dr. Mason is a leading figure in genomics and predictive algorithms for medicine. He is also the author of "The Next 500 Years: Engineering Life to Reach New Worlds."


These press releases may also interest you

at 13:47
Promethean Energy, an oil and gas company focused on stewarding mature assets has started work on the temporary abandonment of 9 orphan wells in the Matagorda Island lease area in the Gulf of Mexico on behalf of the Department of Interior's Bureau of...

at 13:45
Today Logitech (SIX: LOGN) announced that a new Logitech Combo Touch is now available with the redesigned new iPad Air and thin and light new iPad Pro. Made with sustainable and premium materials, the new Combo Touch models are the thinnest and...

at 13:40
MITRE is building a new capability intended to give its artificial intelligence (AI) researchers and developers access to a massive increase in computing power. The new capability, MITRE Federal AI Sandbox, will provide better experimentation of next...

at 13:33
Today, Health Management Associates (HMA) released a new white paper, "Medicare Physician Fee Schedule Reform: Structural Topics and Recommendations to Strengthen the System for the Future." It provides an in-depth analysis of the Medicare Physician...

at 13:30
Open Lockers, the premier smart locker system on the market, has received additional patents, bolstering their integrated retail offering through seamless order pickup and status notifications.  The U.S. Patent and Trademark Office will issue U.S....

at 13:27
The advent of Quantum Computing poses a significant threat to existing public-key cryptosystems. A large quantum computer can break algorithms like RSA or ECDH, which form the backbone of current internet security. Already today, confidential data is...



News published on and distributed by: